Delivery Order SPE2DB22D1202-SPE2DB24FUVN4
- Not listed
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,295.05 fixed-price contract is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a specialty pharmaceutical product, with a completion date of February 21, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with...
- This federal contract award, valued at $2,295.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product, with a performance period through April 9, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $4,590.10 firm fixed price delivery order is for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a specialty pharmaceutical product, in support of military treatment programs and facilities. The award is not set aside and is part of a larger indefinite delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML medical supplies. The $4,590.10 contract has a performance period through March 26, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and no set-aside designations were used. This delivery order is part of a larger indefinite delivery contract (IDC)...
- This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation, is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML. The contract, valued at $1,103.02, is a Delivery Order with a Firm Fixed Price pricing type awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of June 13, 2024 and was awarded on May 22, 2024. This contract is not designated as a set-aside. Amerisourcebergen...
- This federal contract award, valued at $1,195.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product. The contract has an ultimate completion date of June 25, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to various federal agencies,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. under the company's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product, with a firm-fixed price of $1,387.50 and a ceiling value of $1,387.50. The delivery order does not have a set-aside designation and is expected to be completed by August 13,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,390.00 firm fixed-price contract is for the supply of 4567321981 ! RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a medical product used for healthcare purposes. The contract has an ultimate completion date of March 13, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,434.00, is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of March 7, 2025. The contract is for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, which is a medical product used for healthcare purposes. The award is not designated with a set-aside,...
- This federal contract award, valued at $1,836.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a prescription medication. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of July 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUVN4Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $3,309.06 firm fixed price delivery order is for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product. The order has an ultimate completion date of April 23, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 4/2/24 |